Lunai Bioworks Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
1.42
0.00 (0.00%)
At close: Jun 09, 2025, 3:59 PM
Lunai Bioworks Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | 39,683.9B | -118.41M | -115.69M | -80.65M | -53.93M | -41.23M | -41.16M | -31.99M | -99.03M | -100.9M | -103.03M | -113.43M | -40.56M | -38.39M | -34.74M |
Depreciation & Amortization | -113.5B | 125.93K | 126.98K | 121.86K | 118.74K | 116.67K | 112.36K | 85.09K | 85.42K | 158.97K | 231.29K | 331.68K | 602.72K | 531.75K | 461.35K |
Stock-Based Compensation | -3,535B | 3.61M | 4.05M | 4.67M | 4.46M | 3.67M | 2.67M | 1.69M | 1.08M | 1.85K | 1.03K | n/a | 259.82K | 759.25K | 1.12M |
Other Working Capital | 2.79M | 2.26M | 2M | 1.76M | 170.46K | 172.25K | 174.06K | 158.04K | 932.3K | 1.2M | 1.15M | 332.21K | 401.44K | -32.71K | 502.91K |
Other Non-Cash Items | -36,035.4B | 85.61M | 82.68M | 47.53M | 4.93M | 5.26M | 6.14M | 1.51M | 85.61M | 88.15M | 89.94M | 95.53M | 14.04M | 12.45M | 9.23M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8M | 11.02M | 10.2M | 8.81M | 6.1M | 1.61M | 1.6M | 974.13K | 1.84M | 2.58M | 2.01M | 1.42M | 383.6K | -54.89K | 768.4K |
Operating Cash Flow | -8.48M | -9.62M | -10.21M | -10.97M | -10.82M | -11.49M | -11.73M | -8.96M | -9.75M | -9.22M | -10.46M | -15.73M | -25.71M | -25.26M | -23.13M |
Capital Expenditures | 29.77B | -28.85K | -70.43K | -70.43K | -53.02K | -47.73K | -29.77K | -29.77K | -23.63K | -23.63K | n/a | -5.16K | -43.33K | -43.33K | -54.05K |
Cash Acquisitions | n/a | 65.85K | 65.85K | 65.85K | 65.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -29.77B | -181.97K | -197.72K | -1.26M | -1.23M | -1.07M | -1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.52M | -144.97K | -202.3K | -1.26M | -1.21M | -1.12M | -1.09M | -29.77K | -23.63K | -23.63K | n/a | -5.16K | -43.33K | -43.33K | -54.05K |
Debt Repayment | 10.43M | 8.49M | 8.48M | 9.11M | 4.43M | 2.41M | -392.32K | -955.14K | -674.37K | -300K | n/a | n/a | -242.39K | -424.19K | -424.19K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.14M | -2.14M | -1.59M | -1.59M | 341.87K | 341.87K | n/a | -166.63K | 903.57K | 681.4K | 3.63M | 3.8M | 3.95M | 4.17M | 1.18M |
Financial Cash Flow | 10.67M | 9.73M | 9.98M | 10.52M | 9.3M | 8.77M | 5.45M | 2.89M | 2.71M | 834.56K | 4.25M | 4.25M | 32.38M | 35.59M | 32.6M |
Net Cash Flow | 610.3K | 67.78K | -302.9K | -1.65M | -2.64M | -3.87M | -7.45M | -6.1M | -7M | -8.39M | -6.21M | -11.49M | 6.63M | 10.29M | 9.42M |
Free Cash Flow | 11,804.3B | -9.65M | -10.28M | -11.04M | -10.87M | -11.54M | -11.76M | -8.99M | -9.77M | -9.25M | -10.46M | -15.74M | -25.75M | -25.3M | -23.19M |